the pharmacokinetics of doxazosin , following a single oral dose ( 1 mg ) and chronic oral dosing ( doubling doses up to a maximum of 16 mg day-1 ) , were studied in 18 patients with mild to moderate hypertension and stable renal function varying from normal to severely impaired .
C0114873
doxazosin
C0020538
hypertension